Industri

Presentation: PPL Leadership Awards & PPL Innovation Aw...

PPL Conclave 2026 | 13th February 2026 | Hyderabad The post Presentation: PPL L...

Sanofi receives CHMP recommendation for Dupixent approv...

The recommendation applies to children aged two to 11 years experiencing moderat...

BioMarin receives FDA approval for Palynziq use in adol...

This makes Palynziq the only enzyme substitution therapy that received approval ...

India has the infrastructure to lead the global gene th...

AI is often described as a game changer in drug discovery and manufacturing. Wh...

Jubilant Bhartia Foundation & McGill University collabo...

The Jubilant Bhartia Foundation, the CSR arm of the Jubilant Bhartia Group in c...

Made in India – The story of Desh Bandhu Gupta, Lupin a...

Made in India, written by Sundeep Khanna and Manish Sabharwal, traces three rem...

Express Pharma March 2026

India's Foremost Pharma & Biotech Magazine ~ When She Leads The post Express Ph...

BDCDA proposes collaborative model for effective implem...

The Bangalore District Chemists & Druggists Association (BDCDA) has submitted a...

IPA hosts 11th edition of Global Pharmaceutical Quality...

Reportedly, 400+ delegates and 50 speakers were part of the summit The post IPA...

Rare Disease Day – Raising Awareness

Argonaut manufactures orphan drugs, including many personalized medicines for pa...

Commitment, Sustainability, and Trust: The Values Behin...

MVS Omega-3 – commitment, responsibility and trust, not just promises: In today’...

Building India Pharma Inc’s innovation muscle

While we agree that “what got us here (an affordable generics powerhouse) will ...

IPA hosts11th edition of Global Pharmaceutical Quality ...

Reportedly, 400+ delegates and 50 speakers were part of the summit The post IPA...

Traceability is your first line of defence

When patient safety is on the line, you need answers in minutes, not days. As s...

Asahi Kasei to acquire Aicuris Anti-infective Cures for...

The acquisition will expand the company’s speciality pharmaceutical platform int...

Quotient and Ipsen extend partnership for ultra-rare di...

FOP is an ultra-rare condition, impacting fewer than 1,000 people worldwide. The...